Stock ATT ATTENDO AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Attendo AB

Equities

ATT

SE0007666110

Healthcare Facilities & Services

Market Closed - Nasdaq Stockholm
Other stock markets
 17:00:00 28/06/2024 BST 		5-day change 1st Jan Change
43.8 SEK -0.23% Intraday chart for Attendo AB -0.45% +21.33%
05-14 Andreas Koch, Director of Communications, to Leave Attendo AB and His Position in the Executive Management Group CI
05-07 Attendo AB (OM:ATT) commences an Equity Buyback Plan for 14,726,917 shares, representing 9.2% of its issued share capital, under the authorization approved on April 24, 2024. CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,679 7,141 6,195 3,898 5,810 6,897 - -
Enterprise Value (EV) 1 20,510 19,401 19,559 18,196 19,636 22,465 22,212 20,843
P/E ratio 106 x -7.88 x 110 x -86.5 x 15.5 x 16 x 11.4 x 9.68 x
Yield - - - - 2.77% 2.73% 3.33% 3.54%
Capitalization / Revenue 0.73 x 0.58 x 0.48 x 0.27 x 0.34 x 0.37 x 0.34 x 0.33 x
EV / Revenue 1.72 x 1.58 x 1.52 x 1.26 x 1.14 x 1.19 x 1.11 x 1 x
EV / EBITDA 10.6 x 9.45 x 9.03 x 8.37 x 6.45 x 6.68 x 6.11 x 5.62 x
EV / FCF 23.3 x 10 x 16.2 x 10.1 x - 16.7 x 9.27 x 8.42 x
FCF Yield 4.3% 9.96% 6.18% 9.93% - 5.98% 10.8% 11.9%
Price to Book 1.49 x 1.47 x 1.26 x 0.78 x 1.08 x 1.18 x 1.11 x 0.98 x
Nbr of stocks (in thousands) 160,879 160,913 160,913 160,933 160,933 157,471 - -
Reference price 2 53.95 44.38 38.50 24.22 36.10 43.80 43.80 43.80
Announcement Date 13/02/20 10/02/21 10/02/22 10/02/23 08/02/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 11,935 12,288 12,867 14,496 17,287 18,859 19,999 20,922
EBITDA 1 1,940 2,053 2,166 2,174 3,045 3,363 3,635 3,711
EBIT 1 672 673 755 616 1,274 1,404 1,602 1,729
Operating Margin 5.63% 5.48% 5.87% 4.25% 7.37% 7.45% 8.01% 8.26%
Earnings before Tax (EBT) 1 107 -926 103 -42 478 554.9 769.4 916.8
Net income 1 81 -904 56 -45 376 433.1 600.2 715.1
Net margin 0.68% -7.36% 0.44% -0.31% 2.18% 2.3% 3% 3.42%
EPS 2 0.5100 -5.630 0.3500 -0.2800 2.330 2.745 3.827 4.526
Free Cash Flow 1 882 1,932 1,208 1,806 - 1,344 2,397 2,475
FCF margin 7.39% 15.72% 9.39% 12.46% - 7.13% 11.99% 11.83%
FCF Conversion (EBITDA) 45.46% 94.11% 55.77% 83.07% - 39.97% 65.94% 66.69%
FCF Conversion (Net income) 1,088.89% - 2,157.14% - - 310.31% 399.39% 346.1%
Dividend per Share 2 - - - - 1.000 1.195 1.460 1.550
Announcement Date 13/02/20 10/02/21 10/02/22 10/02/23 08/02/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 3,338 3,482 3,546 3,679 3,789 4,044 - 4,767 4,755 4,894
EBITDA 1 511 507 481 673 513 - - 763 998 808
EBIT 1 159 127 91 281 117 226 - 267 506 330
Operating Margin 4.76% 3.65% 2.57% 7.64% 3.09% 5.59% - 5.6% 10.64% 6.74%
Earnings before Tax (EBT) 1 - -42 -68 121 -53 36 - 58 291 118
Net income 1 -9 -33 -63 95 -44 28 63 45 227 92
Net margin -0.27% -0.95% -1.78% 2.58% -1.16% 0.69% - 0.94% 4.77% 1.88%
EPS 2 - - - - - - 0.3900 0.2800 1.430 0.5800
Dividend per Share - - - - - - - - - -
Announcement Date 10/02/22 06/05/22 21/07/22 26/10/22 10/02/23 26/04/23 24/04/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 11,831 12,260 13,364 14,298 13,826 15,568 15,314 13,946
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 6.098 x 5.972 x 6.17 x 6.577 x 4.541 x 4.629 x 4.213 x 3.758 x
Free Cash Flow 1 882 1,932 1,208 1,806 - 1,344 2,397 2,475
ROE (net income / shareholders' equity) 1.39% -17% 4.87% -0.91% 7.26% 7.77% 10% 10.4%
ROA (Net income/ Total Assets) 0.39% -4.49% - -0.21% 1.66% - - -
Assets 1 20,748 20,126 - 21,700 22,608 - - -
Book Value Per Share 2 36.20 30.10 30.70 31.10 33.30 37.00 39.60 44.90
Cash Flow per Share 7.630 14.10 8.560 - - - - -
Capex 1 345 345 142 187 133 189 200 208
Capex / Sales 2.89% 2.81% 1.1% 1.29% 0.77% 1% 1% 0.99%
Announcement Date 13/02/20 10/02/21 10/02/22 10/02/23 08/02/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Attendo AB

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
43.8 SEK
Average target price
57.5 SEK
Spread / Average Target
+31.28%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
ATTENDO AB Stock Attendo AB
+21.33% 651M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.69% 84.15B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-25.20% 74.14B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+1.06% 26.92B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-10.46% 17.15B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.68% 16.83B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-0.73% 15.21B
NATERA, INC. Stock Natera, Inc.
+72.88% 13.3B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+76.04% 12.99B
PURE HEALTH HOLDING Stock Pure Health Holding
-25.79% 12.79B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. ATT Stock
  4. Financials Attendo AB